BeOne Medicines (ONC) Intangibles (2017 - 2026)

BeOne Medicines (ONC) has 10 years of Intangibles data on file, last reported at $61.7 million in Q1 2026.

• Quarterly Intangibles rose 23.02% year-over-year to $61.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $61.7 million (up 23.02% YoY) and the FY2025 annual result came in at $62.7 million, up 22.72% from the prior year.
• Intangibles declined to $61.7 million in Q1 2026 per ONC's latest filing, from $62.7 million in the prior quarter.
• Across five years, Intangibles topped out at $64.9 million in Q2 2025 and bottomed at $39.7 million in Q1 2023.
• The 5-year median for Intangibles is $53.7 million (2023), against an average of $52.1 million.
• The widest annual swing landed in 2022, when Intangibles soared 851.73%; it then dropped 13.26% in 2023.
• Tracing ONC's Intangibles over 5 years: stood at $40.6 million in 2022, then soared by 40.68% to $57.1 million in 2023, then declined by 10.58% to $51.1 million in 2024, then increased by 22.72% to $62.7 million in 2025, then declined by 1.63% to $61.7 million in 2026.
• Per Business Quant, the three latest ONC Intangibles figures stand at $61.7 million (Q1 2026), $62.7 million (Q4 2025), and $63.6 million (Q3 2025).

Peer Comparison